Terns Pharmaceuticals, Inc. Common Stock
Symbol: TERN (NASDAQ)
8.01
▼ (-1.35%) -0.110
Company Description:
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Key Stats
- Today's Open: $7.135
- Today's High: $8.225
- Today's Low: $6.39
- Today's Volume: 4.25M
- Yesterday Close: $8.12
- Yesterday High: $8.63
- Yesterday Low: $7.9
- Yesterday Volume: 3.23M
- Last Min Volume: 1
- Last Min High: $8.01
- Last Min Low: $8.01
- Last Min VWAP: $8.01
Company Profile
- Name: Terns Pharmaceuticals, Inc. Common Stock
- Website: https://www.ternspharma.com
- Listed Date: 2021-02-05
- Location: FOSTER CITY, CA
- Market Status: Active
- CIK Number: 0001831363
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $710.59M
- Round Lot: 100
- Outstanding Shares: 87.51M
- Asset Type: CS
RECENT FILINGS FOR TERN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-22 | 8-K | View |
| 2025-10-02 | 4 | View |
| 2025-09-16 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 8-K | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-05-23 | EFFECT | View |
| 2025-05-21 | CORRESP | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on TERN